Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 450,500 | 436,800 | 430,800 | 439,800 | 433,200 |
| Cost of Goods | 369,400 | 357,600 | 348,200 | 355,500 | 357,600 |
| Gross Profit | 81,100 | 79,200 | 82,600 | 84,300 | 75,600 |
| Operating Expenses | 67,600 | 79,200 | 61,500 | 64,800 | 66,900 |
| Operating Income | 13,900 | 600 | 21,300 | 20,000 | 9,300 |
| Interest Expense | 2,500 | 2,600 | 2,900 | 2,600 | 2,400 |
| Pre-tax Income | 11,400 | -2,000 | 18,400 | 17,400 | 6,900 |
| Income Tax | 7,000 | 4,200 | 8,200 | 6,900 | 3,200 |
| Net Income Continuous | 4,400 | -6,200 | 10,200 | 10,500 | 3,700 |
| Net Income | $4,400 | $-6,200 | $10,200 | $10,500 | $3,700 |
| EPS Basic Total Ops | 0.15 | -0.21 | 0.34 | 0.36 | 0.13 |
| EPS Basic Continuous Ops | 0.15 | -0.21 | 0.34 | 0.36 | 0.13 |
| EPS Diluted Total Ops | 0.15 | -0.21 | 0.34 | 0.35 | 0.12 |
| EPS Diluted Continuous Ops | 0.15 | -0.21 | 0.34 | 0.35 | 0.12 |
| EBITDA(a) | $23,100 | $9,800 | $30,700 | $29,200 | $17,600 |